ALKS
Price
$31.00
Change
-$0.54 (-1.71%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
4.55B
47 days until earnings call
PAHC
Price
$23.89
Change
-$0.08 (-0.33%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
523.71M
83 days until earnings call
Interact to see
Advertisement

ALKS vs PAHC

Header iconALKS vs PAHC Comparison
Open Charts ALKS vs PAHCBanner chart's image
Alkermes
Price$31.00
Change-$0.54 (-1.71%)
Volume$27.76K
Capitalization4.55B
Phibro Animal Health
Price$23.89
Change-$0.08 (-0.33%)
Volume$1.49K
Capitalization523.71M
ALKS vs PAHC Comparison Chart
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. PAHC commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Buy and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALKS: $31.00 vs. PAHC: $23.89)
Brand notoriety: ALKS and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 59% vs. PAHC: 81%
Market capitalization -- ALKS: $4.55B vs. PAHC: $523.71M
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 2 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 2 green, 3 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, ALKS is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 5 bullish, 4 bearish.
  • PAHC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALKS is a better buy in the short-term than PAHC.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а +2.46% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 23, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than ALKS: PAHC (34.11) vs ALKS (8.90). PAHC YTD gains are higher at: 15.284 vs. ALKS (7.771). ALKS has higher annual earnings (EBITDA): 519M vs. PAHC (83.7M). ALKS has more cash in the bank: 773M vs. PAHC (92.5M). ALKS has less debt than PAHC: ALKS (372M) vs PAHC (513M). ALKS has higher revenues than PAHC: ALKS (1.66B) vs PAHC (982M).
ALKSPAHCALKS / PAHC
Capitalization4.55B524M869%
EBITDA519M83.7M620%
Gain YTD7.77115.28451%
P/E Ratio8.9034.1126%
Revenue1.66B982M169%
Total Cash773M92.5M836%
Total Debt372M513M73%
FUNDAMENTALS RATINGS
ALKS vs PAHC: Fundamental Ratings
ALKS
PAHC
OUTLOOK RATING
1..100
2023
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
2176
SMR RATING
1..100
3861
PRICE GROWTH RATING
1..100
5641
P/E GROWTH RATING
1..100
891
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is significantly better than the same rating for ALKS (99) in the Biotechnology industry. This means that PAHC’s stock grew significantly faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (21) in the Biotechnology industry is somewhat better than the same rating for PAHC (76) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew somewhat faster than PAHC’s over the last 12 months.

ALKS's SMR Rating (38) in the Biotechnology industry is in the same range as PAHC (61) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (41) in the Pharmaceuticals Major industry is in the same range as ALKS (56) in the Biotechnology industry. This means that PAHC’s stock grew similarly to ALKS’s over the last 12 months.

ALKS's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for PAHC (91) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew significantly faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSPAHC
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 8 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
63%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SKYU32.280.53
+1.67%
ProShares Ultra Cloud Computing
FYC75.330.22
+0.29%
First Trust Small Cap Gr AlphaDEX® ETF
SAGP31.760.08
+0.24%
Strategas Global Policy Opp ETF
RQI12.44N/A
N/A
COHEN & STEERS QUALITY Income REALTY FUND
BAUG44.24-0.24
-0.54%
Innovator U.S. Equity Buffer ETF Aug

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.95%
PBH - PAHC
49%
Loosely correlated
-0.09%
AMRX - PAHC
44%
Loosely correlated
-3.22%
ZTS - PAHC
40%
Loosely correlated
-1.00%
VTRS - PAHC
38%
Loosely correlated
-1.38%
ELAN - PAHC
35%
Loosely correlated
-0.15%
More